Edition:
United Kingdom

Aclaris Therapeutics Inc (ACRS.OQ)

ACRS.OQ on NASDAQ Stock Exchange Global Select Market

4.89USD
17 Jun 2019
Change (% chg)

$0.22 (+4.71%)
Prev Close
$4.67
Open
$4.80
Day's High
$5.10
Day's Low
$4.64
Volume
228,872
Avg. Vol
165,776
52-wk High
$21.31
52-wk Low
$4.27

About

Aclaris Therapeutics, Inc. is a dermatologist-led, biopharmaceutical company. The Company is focused on identifying, developing and commercializing differentiated drugs for the treatment of dermatological indications. The Company is also focused on the discovery and development of kinase inhibitors to treat inflammatory and... (more)

Overall

Beta: 1.42
Market Cap(Mil.): $192.74
Shares Outstanding(Mil.): 41.27
Dividend: --
Yield (%): --

Financials

  ACRS.OQ Industry Sector
P/E (TTM): -- 103.12 37.45
EPS (TTM): -3.97 -- --
ROI: -66.11 7.69 12.16
ROE: -73.20 8.19 16.93

Earnings vs. Estimates